In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Interest income: |
Interest income on loans | 47.1 | | 29.9 | 27.8 | 26.8 | 27.9 | 25.6 | 25.3 |
Interest income on investments | 7.7 | | 7.8 | 6.8 | 5.7 | 5.6 | 5.7 | 5.2 |
| 56.8 | | 39.0 | 35.8 | 33.3 | 34.4 | 32.1 | 31.1 |
Interest expense: |
Interest on deposits | 4.3 | | 0.6 | 0.5 | 0.6 | 0.7 | 0.6 | 0.6 |
Interest on borrowings | 2.2 | | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 19.2 | | 3.4 | 2.9 | 3.0 | 3.3 | 3.0 | 3.1 |
Net interest income | 48.9 | 42.2 | 37.4 | 34.4 | 31.9 | 32.9 | 30.7 | 29.7 |
Provision for loan losses | -0.2 | | 0.4 | 0.1 | -0.6 | -0.8 | -1.7 | -2.2 |
Net interest income after provision for loan losses | 49.1 | 42.2 | 37.0 | 34.2 | 32.5 | 33.7 | 32.4 | 31.9 |
Other non-interest income | 9.9 | 7.9 | 8.2 | 8.6 | 10.0 | 9.4 | 8.4 | 8.8 |
Total non-interest income | 9.9 | 7.9 | 8.2 | 8.6 | 10.0 | 9.4 | 8.4 | 8.8 |
Non-interest expenses | 34.0 | | 24.0 | 23.8 | 24.2 | 24.4 | 22.2 | 22.2 |
Pre-tax income before non-recurring items | 25.2 | 23.2 | 21.2 | 18.9 | 18.6 | 19.4 | 17.9 | 18.4 |
Non-recurring items | 0.1 | | 0.0 | 0.0 | 0.2 | 0.7 | -0.7 | 0.0 |
Pre-tax income | 25.0 | 23.2 | 21.2 | 18.9 | 18.4 | 18.7 | 18.6 | 18.5 |
Income taxes | 6.6 | 6.1 | 5.6 | 4.9 | 4.8 | 5.1 | 4.9 | 4.8 |
Tax rate | 26.2% | 26.1% | 26.4% | 25.6% | 26.1% | 27.2% | 26.3% | 25.8% |
Net income | 18.5 | 17.2 | 15.6 | 14.1 | 13.6 | 13.6 | 13.7 | 13.7 |
Net margin | 31.3% | 34.3% | 34.5% | 32.9% | 32.0% | 31.6% | 33.6% | 33.8% |
|
Basic EPS | $0.58 | $0.60 | $0.54 | $0.49 | $0.47 | $0.49 | $0.50 | $0.50 |
Diluted EPS | $0.58 | $0.60 | $0.54 | $0.49 | $0.47 | $0.49 | $0.50 | $0.50 |
|
Shares outstanding (basic) | 32.0 | 28.8 | 28.8 | 28.9 | 29.0 | 27.8 | 27.3 | 27.4 |
Shares outstanding (diluted) | 32.1 | 28.8 | 28.9 | 28.9 | 29.0 | 27.8 | 27.4 | 27.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |